Differential diagnosis for a stable patient maintained on buprenorphine who gives a urine toxicology screen negative for buprenorphine.
Department of Psychiatry, Yale School of Medicine, Department of Addiction Psychiatry, West Haven, Connecticut; VA Connecticut Health Care System, West Haven, Connecticut.
Roopa
R
Sethi
Ismene
I
Petrakis
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D002047:Buprenorphine / Q000031:analogs & derivatives / Q000493:pharmacokinetics / Q000627:therapeutic use* / Q000652:urine*; D003937:Diagnosis, Differential; D004347:Drug Interactions; D006801:Humans; D008297:Male; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use / Q000652:urine*; D011241:Prednisone / Q000009:adverse effects; D015813:Substance Abuse Detection / Q000379:methods*
D000893:Anti-Inflammatory Agents; D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine; C043585:norbuprenorphine; D011241:Prednisone